ADMA

Conviction 65HealthcareScan · Mon, Aug 10, 2026

ADMA$9.76-1.46%

ResistanceSupportVol 14Insider buy

Vol MA14 3.2M

May 11May 28Jun 16Jul 6Jul 23Aug 10

ADMA BIOLOGICS, INC.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.admabiologics.com ↗

Price9.76

Change-1.46%

Gap-1.01%

Rel volume3.62×

Avg volume3.16M

Avg $ vol28.59M

SMA 208.86

SMA 508.64

SMA 20013.18

Price vs 50+12.92%

Price vs 200-26.01%

MA stackmixed

50/200 cross—

Supertrendup · 8.81

RSI (14)65

MACD hist0.15

MACD crossbull · 4d

Stoch %K / %D73 / 80

ADX (14)20

+DI / −DI36 / 12

RSI divergence—

MACD divergence—

ATR %+3.87%

ADR %3.46%

52w high20.38

52w low7.60

From 52w high-52.13%

Above 52w low+28.36%

New 52w highNo

SqueezeOff

Bollinger width22.19%

%B0.96

Donchian pos72.77%

Donchian high10.35

Donchian low8.17

AVWAP (52w high)11.25

vs AVWAP high-13.26%

AVWAP (52w low)9.16

vs AVWAP low+6.55%

OBV trendDown

Chaikin MF (20)-0.12

Today vs 20d3.62×

Avg vol (14d)3.2M

Avg vol (20d)3.16M

Avg $ vol (20d)28.59M

Market cap—

RS 3m (vs SPY)+11.19%

RS 6m (vs SPY)-52.01%

RS line new highNo

Trend template2/8

Technical rank39.5

1 week+11.61%

1 month+7.43%

3 months+19.40%

6 months-40.63%

1 year-41.76%

YTD-45.44%

P/E15.06

P/B5.42

P/S4.34

P/FCF79.54

EPS0.6000

Div yield—

ROE35.99%

ROA21.47%

Debt/Eq0.48

Current6.97

EV/EBITDA11.40

Gross margin57.39%

Net margin28.80%

Rev growth19.63%

EPS growth-25.67%

Price target17.00

Target upside72.06%

Analyst ratingBuy

Institutional104.67%

Ent. value2.27B

Revenue124.39M

Net income37.82M

Gross profit86.28M

Free cash flow27.82M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out—

Employees647

ListedThu, Oct 17, 2013

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction65 / 100

Pattern quality—

Tech rank39.5 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance9.84

Support8.20

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in ADMA

All disclosures →

No recent disclosed trades by Congress in ADMA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in ADMA · 5 buys · 1 sell

Insider	Side	Shares	Value	Traded	Filed
Kestenberg-Messina Kaitlin M. COO and SVP, Compliance · Common Stock · 2026-07-24	Tax	3.18K	$27K	2026-07-24	2026-07-28
Kohler Terry CFO and Treasurer · Common Stock · 2026-07-16	Grant	85.13K	—	2026-07-16	2026-07-17
Kohler Terry CFO and Treasurer · Stock Option (Right to Buy) · 2026-07-16	Grant	136.36K	—	2026-07-16	2026-07-17
Grossman Jerrold B Director · Common Stock · 2026-05-27	Other	—	—	2026-05-27	2026-05-28
Grossman Jerrold B Director · Common Stock · 2026-05-27	Buy	6.4K	$51K	2026-05-27	2026-05-28
Grossman Jerrold B Director · Common Stock · 2026-05-12	Other	—	—	2026-05-12	2026-05-14
Grossman Jerrold B Director · Common Stock · 2026-05-12	Buy	12.5K	$100K	2026-05-12	2026-05-14
Grossman Jerrold B Director · Common Stock · 2026-05-11	Other	—	—	2026-05-11	2026-05-12
Grossman Jerrold B Director · Common Stock · 2026-05-11	Buy	12.5K	$100K	2026-05-11	2026-05-12

SEC filings

EDGAR filings in ADMA · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.